Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05761392

APP-based Precise Management System of Chronic Intractable Pain

Led by Beijing Tsinghua Chang Gung Hospital · Updated on 2023-03-09

120

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn about a new management system in chronic and stubborn pain patients who accept therapy of spinal cord stimulation (SCS). Usually, these patients are required to take long-term follow-ups to ensure that the stimulator works well. The main questions it aims to answer are: * Is it better to improve the patient's quality of life than the current conventional follow-up? * Is it better to relieve pain in the long term than the current conventional follow-up? * Is it possible to be applied to a large population of chronic pain patients? Participants will be randomly assigned to either a control group or an interventional group. Participants in the control group will be given the standard SCS implantation surgery and asked to complete the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Participants in the interventional group will be given the standard SCS implantation surgery and asked to do the following things: * Take the daily pain self-assessment questions on a mobile phone APP. * Take the monthly healthy status self-assessment questionnaires on a mobile phone APP. * Take the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Researchers will compare the two groups to see if the life quality of the interventional group is improved.

CONDITIONS

Official Title

APP-based Precise Management System of Chronic Intractable Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinically diagnosed with chronic, intractable pain for more than three months
  • Average pain intensity at enrollment is at least 5 out of 10 cm on visual analogue scale
  • At least 18 years old at enrollment
  • Have ineffective or unsatisfactory conservative treatments such as oral medication, nerve block, epidural corticosteroids, physical and psychological rehabilitation therapy, or chiropractic care
  • Voluntary participation with signed informed consent
  • Good compliance and ability to complete post-operative follow-ups
  • Basic ability to read and use a mobile phone or have a caregiver who can
Not Eligible

You will not qualify if you...

  • Bleeding complications or coagulation disorders
  • Mental or cognitive disorders preventing surgery or follow-up
  • Spinal cord or vertebrae issues unsuitable for implantation surgery
  • Systemic active infections or local infections near surgery area
  • Pregnant, breastfeeding, planning pregnancy, or unwilling to use contraceptives
  • Metastatic or untreated malignant tumors
  • Life expectancy less than one year
  • Already have a medication pump or other implanted devices
  • Require therapy or exams incompatible with implanted pulse generator, such as MRI or thermotherapy
  • Heavy addiction to alcohol or drugs
  • Less than 50% improvement in pain or intolerance to stimulation during test period
  • Unable to complete long-term online follow-ups due to hardware issues like internet or mobile phones
  • Unwilling to participate
  • Other inappropriate situations determined by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Tsinghua Chang Gung Hospital

Beijing, China

Actively Recruiting

Loading map...

Research Team

Y

Yang Lu, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here